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This newsletter was jointly developed and 
subject to editorial review by Jefferson 
School of Population Health and Lilly 
USA, LLC, and is supported through 
funding by Lilly USA, LLC.  The content 
and viewpoints expressed are those of the 
individual authors, and are not necessarily 
those of Lilly USA, LLC or the Jefferson 
School of Population Health.
As I reviewed the articles for this issue 
of Prescriptions for Excellence in Health 
Care, I found myself wondering about 
the future of the National Quality Forum 
and the important priorities established 
by the National Priorities Partnership 
(NPP).  Who will advance the agenda for 
high-quality, safe, patient-centered health 
care in the future?
The answer to my question became 
apparent when I attended the 2nd 
Annual American Medical Student 
Association Quality and Safety Institute. 
Over the course of this 3-day event, 
more than 20 medical and premedical 
students learned about cultural barriers 
to quality, tools to measure quality, 
and strategies to advance projects at 
their home institutions.  The timely 
and informative sessions were taught 
by faculty from the Jefferson School of 
Population Health, Drexel University 
College of Medicine, The National 
Board of Medical Examiners, New 
York Hospital Cornell Medical Center, 
Robert Wood Johnson Medical School, 
and Christiana Care (DE). 
The bottom line is that quality and 
safety can no longer be “electives” in 
a medical school curriculum.  While 
most current faculty lack knowledge and 
expertise in this field, today’s students 
will ensure that this critical information 
becomes part of the standard medical 
school curriculum of the future.  
Moreover, they will put the information 
to use in their professional lives – 
following the fine examples set forth by 
the authors in this issue.  
The lead article, “Practical Ideas for 
Patient and Family Engagement in 
Health Care,” offers hospitals and health 
systems several practical, easily applied 
suggestions for involving patients 
and families in their health care.  The 
following article, “Care Coordination 
in the Context of a Population Health 
Management Model,” describes the 
breadth and depth of this relatively  
new field as it relates to the NPP goal  
of care coordination. 
The third article,  “Leapfrog: Unique 
and Salient Measures of Hospital Quality 
and Safety,” describes a successful, high-
impact health care reform initiative that 
Editorial
A New Generation of Quality Advocates
By David B. Nash, MD, MBA
Editor-in-Chief
Prescriptions for Excellence in
H E A LT H  C A R E
Prescriptions for Excellence in Health 
Care is brought to Health Policy 
Newsletter readers by Jefferson School 
of Population Health in partnership 
with Lilly USA, LLC to provide 
essential information from the quality 
improvement and patient safety arenas.
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originated in the private purchaser sector. 
The goal of “eliminating overuse while 
ensuring the delivery of appropriate 
care” is addressed in terms of reduction 
of unwarranted procedures in the final 
article, “Applying Appropriateness Methods 
to Address Overuse While Ensuring 
the Delivery of Appropriate Care: The 
Example of Cardiac Revascularization.” 
I hope that these articles will inspire 
readers to become advocates for 
the NPP’s National Priorities and 
Goals within their organizations and, 
equally important, will champion the 
case for quality and safety in medical 
school curricula.  
As always, I am interested in your 
feedback; you can reach me by e-mail 
at: david.nash@jefferson.edu or visit my 
blog at: nashhealthpolicy@blogspot.com. 
David B. Nash, MD, MBA is 
Founding Dean and the Dr. Raymond 
C. and Doris N. Grandon Professor, 
Jefferson School of Population Health.
With the passage of the Health 
Information Technology for 
Economic and Clinical Health Act, 
the United States has demonstrated 
a commitment to speeding the 
adoption of electronic medical 
records (EMRs) by health care 
providers.1 The promise of health 
information technology (HIT) 
often focuses on the use of EMRs 
and health information exchanges 
to improve the information 
available to health care providers 
for the delivery of care to individual 
patients.  Increasingly, the health 
care community also is recognizing 
the opportunity to improve service 
delivery by leveraging HIT to gain 
population-level insights about 
targeted interventions.  
Post-market medication safety 
surveillance is an important 
illustration of the potential utilization 
of HIT for population-level health 
care information.   While extensive 
clinical trials prior to a medication’s 
launch provide critical information 
about the benefit-risk profile of a 
medication, patient safety is promoted 
further through information gained 
once the medication is being used in 
clinical practice.  
Post-market efforts to refine the 
understanding of the benefit-risk 
profile of a medication include 
both passive and active surveillance 
systems.  Recently, the importance of 
HIT in improving active surveillance 
has received increased focus as the 
Food and Drug Administration 
(FDA) has moved forward with the 
development of the FDA Sentinel 
Network Initiative, an effort to 
utilize large health care databases to 
actively detect potential medication-
related adverse events.2 
Eli Lilly and Company has 
worked to contribute to the 
understanding of HIT-enabled active 
surveillance through involvement 
in multistakeholder pilot projects 
including the Observational Medical 
Outcomes Partnership3 and the 
eHealth Initiative’s Connecting for 
Drug Safety Collaboration.4
Complementing active surveillance 
efforts, the passive surveillance 
system relies on health care providers 
and others to voluntarily submit 
information on suspected medication-
related adverse events to the FDA 
through paper-based or Web-based 
reports to the FDA’s MedWatch 
program.5  MedWatch reports 
include clinical information that 
helps regulators and manufacturers 
to evaluate the potential relationship 
between a marketed medication 
and an adverse event.6  However, a 
number of factors, including perceived 
time limitations of busy clinicians, 
may hinder the ability of providers  to 
initiate efforts to populate and submit 
these forms with the information that 
would best facilitate evaluation.  
Lilly, along with a number of other 
stakeholders, recognizes that the 
passive surveillance system also has 
the potential to be enhanced through 
HIT.  The digitalization of health 
care information through HIT may 
offer an opportunity to improve the 
quantity and quality of MedWatch 
reports by auto-populating important 
MedWatch fields with electronic 
information from the EMR or health 
information exchanges.  
Project REPORT (Reporting Events 
and Patient Outcomes Related to 
Therapy) is a recent collaboration 
between Lilly and Dr. Atif Zafar’s 
team from the Regenstrief Institute 
and the Indiana University (IU) 
School of Medicine.  For this pilot 
project, Dr. Zafar’s team created a 
Web-based MedWatch form that 
could be populated with data from 
the Indiana Health Information 
Exchange (IHIE).   After being 
made aware of the new system, 
providers at IU primary care clinics 
had the ability to prepare MedWatch 
forms that included imported 
IHIE data on comorbid conditions, 
concomitant medications, and 
A Message from Lilly
Project REPORT: Leveraging Health Information Technology to Improve Patient Safety
By Kraig Kinchen, MD
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Practical Ideas for Patient and Family Engagement in Health Care
By Maulik Joshi, DrPH
A few years ago, my then 7-year-old 
daughter was hospitalized for asthma 
complications. When my wife walked 
into the hospital room and saw our 
daughter’s medical chart on a cart by 
the door, she began to look through it, 
trying to understand the information. 
A nurse walking by told my wife that 
she could not look at the chart.  She 
whisked it away to the nurses’ station. 
Although we noticed medical charts 
outside of other patient rooms, we 
never saw our daughter’s chart again.  
As clinicians stood outside our 
daughter’s room discussing her case 
before discharge, my wife and I felt like 
outsiders. We wanted to know what 
we could do to control our daughter’s 
asthma so she would not return to 
the hospital. But our conversations 
with the medical team left us without 
answers to our questions.  Every 
conversation ended with a practitioner 
telling us to call the outpatient clinic 
and make an appointment with the 
pediatric pulmonologist. 
Did we receive outstanding care at 
this hospital? Yes. How was the staff?  
Heroic. Could the system have better 
engaged us in our daughter’s care for a 
better health outcome? Absolutely!
The National Priorities Partnership 
(NPP) has identified patient and 
family engagement in health care as 
1 of its 6 National Priorities -  “…to 
make health care safer, more patient-
centered, affordable, and effective.”1 
Patients and their families want to 
become more involved in managing 
their health care and making decisions 
about treatment and procedures. 
Research has shown that engaged 
patients help achieve better health 
outcomes, lower service utilization, 
and lower costs.2 
 The NPP set 3 goals to engage 
patients and families: 
•	 All patients will be asked for 
feedback about their experience of 
care, and this information will be 
used by health care organizations 
and their staff to improve care.
•	 All patients will have access to 
tools and support systems that 
enable them to effectively navigate 
and manage their care.
relevant lab values.  Subsequent to 
including a brief narrative on the 
potential adverse event and some 
additional information, the provider 
could review the form and have it 
sent to the FDA through Project 
REPORT.  Reflecting on the Project 
Report pilot project, Dr. Zafar stated, 
“The REPORT system provides a 
mechanism for providers to quickly 
report important adverse drug events 
that would otherwise go unreported 
due to the time burdens associated 
with the reporting process.”  His 
team is in the process of improving 
the system as well as looking for 
opportunities for partnerships that 
would extend the system to other 
health care providers that participate 
in IHIE.  
What is learned from Project 
REPORT will contribute to the 
growing body of information that 
can be gained from other efforts to 
leverage HIT to enhance the passive 
surveillance system.  The ASTER 
(ADE Spontaneous Triggered Event 
Reporting) Project, a collaboration 
between Partners Healthcare, Pfizer, 
and others, represents a significant 
effort to enable clinicians to auto-
populate MedWatch fields using 
EMR data.7 
Lilly hopes that such initiatives will 
stimulate further multistakeholder, 
collaborative efforts to improve 
adverse event reporting.  The timely 
evaluation of data can promote a 
more thorough understanding of a 
medication’s benefit-risk profile and 
enable clinicians to enhance patient 
safety at the point of care.
Kraig Kinchen, MD, is Senior Advisor 
to Electronic Exchange of Healthcare 
Information at Eli Lilly and Company.
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•	 All patients will have access  
to information and assistance  
that enables them to make 
informed decisions about their 
treatment options.1
The NPP also emphasizes shared 
decision making as an important 
underlying goal in health care —
calling for it to be “the norm for most 
diagnostic and treatment processes.”1 
To help achieve these goals, I offer 
the following practical suggestions for 
involving patients and families in their 
health care.  I believe that these ideas 
have merit and are worth testing as a 
means for achieving our overall aim.  
Involve patients and families in the design 
and redesign of care. 
Asking patients for feedback typically 
means distributing patient satisfaction 
questionnaires, but it also can include 
hands-on involvement for patients. For 
example, hospitals and health systems 
could include patients and families 
on care improvement teams and 
advisory councils. Such involvement 
gives patients formal opportunities to 
participate more directly in the design 
and redesign of processes, and their 
involvement and feedback helps to 
accelerate the pace of improvement. 
Engage patients and families in the  
care process.  
Two years ago, the Agency for 
Healthcare Research and Quality 
and the Ad Council launched a 
patient involvement campaign with 
a Web site called “Questions Are 
the Answer” (http://www.ahrq.gov/
questionsaretheanswer/).  The site 
features a “question builder” that helps 
patients prepare a list of questions for 
medical appointments. The message to 
patients is clear: get more involved in 
your health care. 
Hospitals and health systems can 
engage patients in the care process by 
including them and their families in 
multidisciplinary daily patient rounds. 
A study by Rosen et al compared and 
evaluated conventional rounds with 
family-centered multidisciplinary rounds 
in an inpatient pediatric ward. After 
family-centered rounds, the staff reported 
better understanding of patients’ medical 
plans, better ability to help the families, 
and a greater sense of teamwork.3 
Scheduling liberal visiting hours is another 
way to engage families. A research trial 
showed a positive clinical impact with a 
more flexible and open visiting policy in 
the intensive care unit.4 By participating 
in the care process through rounds or 
hospital visits and being prepared for 
appointments, patients and families have 
direct access to tools and support systems 
that help them manage their care.
Provide patients and families with 
easily accessible, meaningful, and 
understandable information.   
Hospitals and health systems can 
begin by giving patients full and easy 
access to their personal health records. 
Ross and Lin reviewed outcomes 
from several studies in which patients 
were permitted access to their health 
records. They concluded that giving 
patients such access showed “modest 
improvements in doctor-patient 
communication, adherence, patient 
empowerment, and patient education.”5 
Along with access to health records, 
providing customized educational 
materials for each patient is important. 
Customized materials are written in 
the patient’s preferred language and at 
an appropriate reading level. Ease of 
reading is very important. NPP cites a 
recent study that found that over 75% 
of patients discharged from emergency 
departments do not understand the 
information or instructions they 
receive. More alarming, a majority of 
these patients do not realize that they 
lack understanding.6 
In addition to providing understandable 
information, accommodating each 
patient’s language preferences and 
cultural needs ensures that the hospital 
or health system is providing patient-
centered care.
Address needs of patients and families 
with limited English proficiency (LEP). 
A national study conducted by the 
Health Research & Educational Trust 
found that 80% of hospitals encounter 
LEP patients “frequently,” defined as 
at least monthly and often weekly or 
daily. Surveyed hospitals identified over 
30 languages they had encountered, 
from Spanish (encountered by 93% 
of the hospitals) to Tagalog and Thai 
(encountered by 21% and 20% of the 
hospitals, respectively).7 
Strategies to address the needs of 
LEP patients and families include: 
establishing a centralized program or 
department to coordinate language 
services; implementing remote or 
telephonic interpretation; hiring trained 
medical interpreters in high-volume 
languages and bilingual staff members 
with training in medical interpretation; 
providing training to clinicians on how 
to access and work with interpreters; and 
designating more positions—particularly 
clinical positions—as bilingual.
Transparency is an additional goal 
when engaging patients and families. 
Many hospitals and health systems 
currently report clinical outcomes 
including comparative costs and 
quality information.  As a result, 
many health care consumers are 
gathering information before seeking 
medical treatment. Hospitals and 
health systems must ensure that the 
information they provide is relevant 
and useful.  In a recent article on 
“patient-centeredness,” Berwick 
suggested that hospitals “extend 
transparency to all aspects of care, 
including science, costs, outcomes, 
processes, and errors.”8 
Conclusion:  
During my daughter’s hospital stay, 
my wife and I wanted to become 
more engaged in the care process. 
Participating in rounds, having access 
to her health record, or sharing in 
decision making would have made us 
feel less like outsiders and more like 
active participants in her care. Many 
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hospitals and health systems are doing 
more and doing better at engaging 
patients and families in the care 
process.  The journey continues.
Maulik Joshi, DrPH, is President of the 
Health Research & Educational Trust 
and Senior Vice President for Research at 
the American Hospital Association. He 
can be reached at: mjoshi@aha.org.
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Population health management 
encompasses a broad continuum of care 
services, from wellness and prevention 
through disease management and 
complex case management.  This 
continuum of care represents the 
evolution of the traditional disease 
management industry from one focused 
on managing single chronic conditions 
to one focused on managing multiple 
comorbidities.  It recognizes that early 
intervention can keep healthy people well, 
help those who are at risk stave off the 
development of chronic conditions, and 
educate those with chronic illnesses about 
condition management techniques to 
mitigate complications and exacerbations.
DMAA: The Care Continuum Alliance 
provides services along all points of 
this continuum - from wellness to 
population health management to 
disease management - via its member 
organizations, which include health plans, 
labor unions, employer organizations, 
pharmaceutical manufacturers, 
pharmacy benefit managers, health 
information technology innovators 
and device manufacturers, physician 
groups, hospitals and hospital systems, 
and academicians.  These diverse 
organizations share DMAA’s vision of 
aligning all stakeholders to improve the 
health of populations. Members seek to 
maintain and improve health care quality 
and restrain health care costs by providing 
targeted interventions and services to 
individuals who are well, at-risk, or 
managing 1 or more chronic conditions.
The expansion of services to encompass 
a full continuum of care, along with 
the dramatic expansion of population 
health management providers, 
highlights the importance of careful 
coordination of services and providers.  
With the evolution from single-state 
disease management to population 
health management strategies, the focus 
is on techniques and tools for improved 
care coordination.  
Population Health Management Model  
On behalf of the population health 
management industry, DMAA: The 
Care Continuum Alliance advances a 
population health improvement model 
that contains the elements of a fully-
connected health care system to provide 
all members of the health care team 
with essential tools to ensure proactive, 
coordinated, quality health care. The 
population health improvement model 
highlights 3 components: 
•  the central care delivery and leadership 
roles of the primary care physician; 
•  the critical importance of patient 
activation, involvement, and personal 
responsibility; and 
•  the patient focus and capacity for 
increased care coordination engendered 
by wellness, disease, and chronic care 
management programs. 
The convergence of these roles, resources, 
and capabilities in the population health 
improvement model ensures higher 
levels of quality and satisfaction with 
care delivery. Further, coordination 
and integration are important tools to 
address health care workforce shortages, 
individual access to coverage and care, 
and affordability of care.
Accountability must be assigned for 
delivering and coordinating appropriate 
cost-effective care.  Likewise, the 
achievement of targeted improvement 
and goals for population health must be 
explicitly recognized and proportionately 
rewarded. To this end, the population 
Care Coordination in the Context of a Population Health Management Model
By Tracey Moorhead
(continued on page 6)
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health improvement model envisions 
optimizing physician office practices and 
other services that improve population 
health and add value. To best achieve 
this, payers, purchasers, patients and 
their advocates, and other members 
of the health care team must promote 
and ensure appropriate reimbursement 
schedules for cognitive services, care 
coordination, referral activities, and 
adherence to desired processes such as the 
use of evidence-based clinical guidelines.
Key components of the population 
health improvement model include: 
•  population identification strategies  
and processes; 
•  comprehensive assessments of  
physical, psychological, economic,  
and environmental needs; 
•  proactive health promotion programs 
that increase awareness of the health 
risks associated with certain personal 
behaviors and lifestyles; 
•  patient-centric health management 
goals and education, which may 
include primary prevention, behavior 
modification programs, and support  
for concordance between the patient 
and the primary care provider; 
•  self-management interventions aimed  
at influencing the targeted population  
to make behavioral changes; 
•  routine reporting and feedback loops, 
which may include communications 
with patients, physicians, health plans, 
and ancillary providers; 
•  evaluation of clinical, humanistic, and 
economic outcomes on an ongoing 
basis with the goal of improving overall 
population health.
The population health improvement 
model supports care coordination goals 
in a wide variety of ways.  First and 
foremost, it encourages patients to have 
a provider relationship whereby they 
receive on going primary care in addition 
to specialty care, and complements 
the physician/practitioner and patient 
relationship and plan of care across all 
stages, including wellness, prevention, 
chronic, acute, and end-of-life care.  
The model supports physicians by 
offering additional resources to address 
gaps in patient health care literacy, 
knowledge of the health care system, and 
timeliness of treatment.  It also provides 
technical assistance to physicians – from 
collecting, coordinating, and analyzing 
patient-specific information and data 
from patients and multiple members of 
the health care team to analyzing data 
across entire patient populations.  
Further, the model assists unpaid 
caregivers, such as family and friends, 
by providing relevant information and 
care coordination, and by addressing 
cultural sensitivities and preferences of 
individuals from disparate backgrounds. 
Finally, the model promotes 
care coordination by promoting 
complementary care settings and 
techniques, such as group visits, remote 
patient monitoring, telemedicine, 
telehealth, behavior modification, and 
motivation techniques, for appropriate 
patient populations.
Accountable measurement of progress 
toward optimized population health 
should include various clinical indicators 
including process and outcomes 
measures; assessment of patient 
satisfaction with health care; functional 
status and quality of life; economic 
and health care utilization indicators; 
and impact on known population 
health disparities.  These indicators 
can demonstrate the effectiveness of 
coordination activities across services 
and providers.
Care Coordination in Population Health 
Management
As already described, population 
health management is a system of 
coordinated health care interventions 
and communications for at-risk and 
chronically ill populations.  Population 
health management supports care 
coordination by facilitating/supporting 
integration across providers or care 
settings to link chronically ill individuals 
and their families with health education 
and appropriate services and resources.  
Care coordination also includes 
interrelationships across health care 
services and strategies, from primary 
prevention and acute care to chronic 
and end-of-life care.  As such, care 
coordination is a central component of 
population health management.  
The National Priorities Partnership, 
convened by the National Quality 
Forum (NQF), has established 6 
key goals to transform health care 
and create and expand world-class, 
patient-centered, affordable care by 
eliminating waste, harm, and disparities, 
and thereby reducing disease burden.  
Care coordination to ensure patient-
centered, high-value care is among 
these priorities and associated quality 
goals include improved communication 
and medication management during 
transitions in care and reductions in 
30-day readmissions and emergency 
department visits.
The NQF defines “care coordination” 
as “a function that helps ensure that 
the patient’s needs and preferences for 
health services and information sharing 
across people, functions, and sites are 
met over time.  Coordination maximizes 
the value of services delivered to patients 
by facilitating beneficial, efficient, safe, 
high-quality patient experiences and 
improved health care outcomes.”  
The NQF has designed 5 care 
coordination domains: 1) health care 
“home”; 2) proactive plan of care 
and follow up; 3) communication; 4) 
information systems; and 5) transitions 
and “handoffs.”  The population health 
model encompasses these 5 domains to 
achieve improved care coordination.  
Summary
The population health improvement 
model represents the evolution 
of traditional, single disease state 
management by facilitating and ensuring 
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Leapfrog: Unique and Salient Measures of Hospital Quality and Safety
By Leah Binder 
Health care reform initiatives from 
the public sector dominate the 
headlines.  Lesser known, but equally 
dramatic, are reform initiatives 
grown in the private sector. In fact, 
many valuable lessons learned from 
health benefits purchasers’ initiatives 
have been incorporated into policy 
makers’ proposals for health care 
reform at the federal and state levels. 
These purchaser initiatives have had 
a dramatic impact on the delivery of 
health care in the United States.
The Leapfrog Group (Leapfrog) is the 
purchaser’s foremost agent of change 
in the health care system.  Founded in 
the year 2000 by large employers and 
business groups on health, Leapfrog 
aims for “giant leaps forward in the 
quality, safety, and affordability of 
health care.”  To accomplish this, 
Leapfrog collects and publishes a 
“dashboard” of information on hospital 
performance and supports purchasers 
in using that information to structure 
their purchasing decisions.  Data are 
collected on performance measures 
via an annual voluntary Leapfrog 
Hospital Survey.  Results, including 
comparisons of performance among 
hospitals, are reported publicly.  The 
current report contains data from more 
than 1200 US hospitals.  Leapfrog 
organization members (purchasers) 
agree to use the information in their 
health purchasing decisions. 
Research shows that if 3 of Leapfrog’s 
standards (ICU staffing, electronic 
medication ordering systems, and 
use of higher performing hospitals 
for high-risk procedures) were 
implemented in all urban US hospitals, 
the nation could save as many as 
57,000 lives, avoid as many as 3 
million adverse drug events, and save 
up to $12 billion in health care costs 
each year.1
Leapfrog measures are endorsed by 
the National Quality Forum (NQF) 
and/or are consistent with those 
of The Joint Commission and the 
Centers for Medicare and Medicaid 
Services.  Although the measures are 
standardized, the information Leapfrog 
collects from them is not readily 
available elsewhere.  Leapfrog publicly 
reports and compares the variable 
performance of each participating 
hospital on a national scale, yielding 
a unique report that reveals salient 
information about hospital quality.   
Selected by purchasers, Leapfrog 
measures are those of greatest 
importance and impact to consumers 
and include: hospital mortality rates 
for high-risk and common procedures, 
whether hospitals undertake endorsed 
methods for reducing infection, whether 
hospitals deploy endorsed safe practices, 
and whether hospitals have in place 
management protocols and technology 
that has reduced ICU deaths by 40% or 
medication errors by 85%. 
Because Leapfrog collects data that 
is otherwise publicly unavailable and 
considers measures with the greatest 
impact on consumers, the results of the 
survey attract considerable attention. 
The results allow policy makers and 
planners to pinpoint weaknesses in 
safety, quality, and affordability in 
US hospitals. Indeed, results from 
the 2008 survey included specific 
metrics to identify improvements 
hospitals must undertake to achieve 
performance levels that warrant the 
high price Americans pay for their 
health care. 
Leapfrog findings from 1256 reporting 
hospitals include:
•  Two thirds of hospitals do not have all 
of the NQF-endorsed safe practices in 
place to prevent infections.
•  Fewer than 1 in 4 hospitals meet 
efficiency standards for heart bypass 
surgery or angioplasty.
•  Three quarters of hospitals fail 
Leapfrog’s mortality standards for 
pancreatic resection.
•  Only one third of hospitals have 
ICU coverage that meets Leapfrog 
standards.
•  Only 7% of hospitals meet Leapfrog 
standards for having in place the 
technology known to prevent 
medication errors.
•  There is a 10-fold variation between 
hospitals with the lowest rates of 
patient-focused care coordination to 
improve the quality of health care 
provided to individuals across the 
continuum of care and services.  The 
population health improvement model 
is closely aligned with the National 
Priorities Partnership’s efforts to improve 
care coordination. Aligning the goals 
and components of care coordination 
offered by DMAA: The Care 
Continuum Alliance, the NQF, and the 
National Priorities Partnership enables 
the dissemination of a comprehensive 
tool that all stakeholders can utilize as 
they transition from single condition 
programs, created and delivered in a 
silo, to whole person, whole population 
health management. 
Tracey Moorhead is President and Chief 
Executive Officer of DMAA: The Care 
Continuum Alliance.  She can be reached 
at: tmoorhead@dmaa.org.
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Applying Appropriateness Methods to Address Overuse While Ensuring the 
Delivery of Appropriate Care: The Example of Cardiac Revascularization
By David J. Ballard, MD, MSPH, PhD
The National Priorities Partnership 
(NPP) identified “eliminating 
overuse while ensuring the delivery of 
appropriate care” as 1 of its 6 Priorities 
and Goals. Within this goal, one area 
of concentration is the reduction of 
unwarranted procedures, including 
coronary revascularization procedures 
such as coronary artery bypass grafting 
(CABG) and percutaneous coronary 
intervention (PCI).1 These goals are 
laudable; currently, CABG is the most 
common type of open-heart surgery 
in the United States, with 500,000 
surgeries performed per year at a 
total annual cost of $50 billion. Also 
common and costly,  approximately 1.3 
million PCI procedures are performed 
in the United States each year at a total 
cost of $60 billion.2
There is likely to be a larger 
opportunity to reduce overuse of PCI 
procedures than CABG procedures. 
Application of RAND methodology 
to determine appropriateness of 
cardiac revascularization procedures 
in 3960 Medicare beneficiaries 
in 1991 and 1992 demonstrated 
that 14% of PCI procedures were 
inappropriate.3 The percentage of 
inappropriate PCI procedures varied 
from 4% to 24% across states, and half 
of all PCI procedures were rated as 
having uncertain appropriateness. For 
CABG, variation across states was less 
pronounced, with 10% of procedures 
rated as inappropriate (ranging from 
0% to 14%), and only 15% of CABG 
surgeries rated as having uncertain 
appropriateness.4 
Studies of cardiac revascularization in 
New York demonstrated lower rates of 
inappropriate use of PCI and CABG 
within that state. For patients who 
underwent PCI or CABG in 1990, 
the inappropriate rate of PCI use was 
4% for men and 3% for women (with 
34% and 40% of procedures having 
uncertain appropriateness for men 
and women, respectively); the rate of 
inappropriate use for CABG was 2% 
for men and 3% for women (with 7% 
pressure ulcers and those with the 
highest rates.
Overall, the survey results are 
disappointing; with regard to variation 
among hospitals, the results raise 
serious concerns.  Depending on 
the measure, the highest performing 
hospitals’ metrics exceed those of the 
lowest performing hospitals by 4 to 
10 times.  Clearly, there is substantial 
opportunity for improvement by the 
vast majority of reporting hospitals.     
Employers throughout the country 
use Leapfrog as a platform for 
conversations and contracting with 
hospitals.  Some employers utilize 
Leapfrog results as a tool in benefit 
design and in pay-for-performance 
programs. In addition, Leapfrog results 
are commonly used by employers to 
inform employees about the relative 
value of hospitals in their regions.  
On a policy level, Leapfrog is one of 
the nation’s pioneering champions of 
value-based purchasing (ie, using good 
data on hospital performance to set 
reimbursement rates).  Leapfrog works 
with policy makers and federal agencies 
to help structure new value-based 
purchasing strategies for Medicare and 
for health care reform proposals.  
Leapfrog’s policy on withholding 
payment for “never events” (28 serious 
adverse events defined by the NQF 
including objects left in after surgery or 
surgery on the wrong site) is consistent 
with its overarching principle of tying 
payment to performance. Leapfrog was 
the first national organization to issue 
a recommended policy on never events.  
In addition to calling for hospitals to 
waive all costs associated with the never 
event, Leapfrog’s policy has 3 other key 
features: 1) apologize to the patient, 2) 
report the event to qualifying agencies, 
and 3) conduct a root cause analysis to 
prevent recurrence.
The Leapfrog Survey raises serious 
and disturbing questions about the 
quality and cost-effectiveness of 
American hospitals.  With the advent 
of health care reform, Leapfrog and its 
purchaser members seek opportunities 
to share lessons learned.  Our national 
experience demonstrates the value of 
transparency when communicating 
quality and cost-efficiency 
information, as well as the advantage 
of tying reimbursement policies to 
performance.  Collaboration among 
the private and public sectors to shine 
light on and reward the highest levels 
of achievement among hospitals will 
be essential to improve the quality 
and cost-effectiveness of care in the 
coming decades.  
Leah Binder is Chief Executive Officer of 
The Leapfrog Group.  She can be reached 
at: lbinder@leapfroggroup.org.
References:
1.     Lwin AK, Shepard DS. Estimating Lives and Dollars 
Saved from Universal Adoption of the Leapfrog Safety and 
Quality Standards: 2008 Update.  Washington, DC: The 
Leapfrog Group; 2008.
9Prescriptions for Excellence in Health Care
of CABGs rated as having uncertain 
appropriateness).5 Other studies of 
cardiac revascularization in New York 
have confirmed these rates6, 7 and drawn 
attention to the larger proportion of 
uncertain appropriateness associated 
with PCI procedures.7 
Cross-state studies have been 
more likely to examine CABG 
appropriateness than PCI 
appropriateness, and have found low 
rates of inappropriate and uncertain 
CABG use. In a study of patients who 
underwent CABG surgery in 1990 
in 12 US Academic Medical Center 
Consortium hospitals, 2% of these 
procedures were rated as inappropriate 
and 7% were rated as having uncertain 
appropriateness.8 More recently, a 
study of 4684 CABG procedures 
performed in 2004 and 2005 in 
northern New England demonstrated 
an appropriateness rate of 99%.9 
Despite general consensus among 
experts about when CABG is 
appropriate, questions have been raised 
about the effectiveness of the procedure, 
particularly for women.10 Early 
studies suggested that women were 
more likely than men to experience 
in-hospital mortality and morbidity 
after CABG, although long-term 
survival and functional recovery were 
similar in women and men.11, 12 More 
recent studies have suggested that this 
difference may be observed because 
women have a disadvantageous 
preoperative clinical profile (eg, older 
age, poorer left ventricle function, 
more comorbid conditions).13, 14 
Smaller coronary arteries in women 
may also contribute to a higher risk of 
in-hospital mortality and morbidity 
following CABG surgery.15 
Other researchers have found that 
operative mortality is higher for women 
even after adjusting for comorbidities, 
and have suggested that this may be 
due to a referral bias that results in 
later referrals for women and treatment 
that occurs later in the course of the 
disease.16  Overall, however, in-hospital 
mortality and morbidity and long-term 
survival appear to be related more to 
risk factors and patient characteristics 
than to gender.10 As mentioned, rates 
of inappropriately used CABG surgery 
were found to be low and similar for 
men and women.5
There is scant evidence to date that the 
multiyear work of the cardiovascular 
physician community to produce 
appropriateness ratings for cardiac 
revascularization will have an impact on 
achieving the NPP Priorities and Goals.17 
Studies have not yet examined changes 
in appropriate CABG and PCI use after 
implementation of specific interventions 
to improve rates of appropriate use. 
The development of such interventions 
should form an important focus for 
future research efforts.
An additional area for future research 
is the development of concurrent data 
collection tools to support real-time 
clinical decision making regarding the 
appropriateness of PCI and CABG 
surgery.18 Despite the availability of a 
data collection tool,19 there has been no 
effort to connect the data collected to 
algorithms linked to American College 
of Cardiologists’ appropriateness 
ratings that enable classification of a 
prospective candidate for PCI. 
Examples of real-time decision-support 
tools include evidence-based guidelines 
that are integrated into practice 
through electronic or paper-based 
flow sheets and reminders, computer-
assisted diagnosis tools, and mandatory 
solicitation of a second opinion for 
high-risk procedures such as CABG 
that are classified as inappropriate or as 
having uncertain appropriateness.20, 21 
Such tools can improve evidence-based 
clinical decision making and use of 
appropriate care.22, 23
Even with clinical decision-support 
tools, large reductions in the overuse 
of PCI are unlikely to occur without 
associated financial “carrots and sticks” 
that are yet to be defined. A variety of 
financial incentives have been used to 
contain costs associated with surgeries 
that may be overused. As health care 
costs accelerated in the 1970s, payers 
began to institute the first surgical 
second opinion programs (SSOPs) 
and precertification requirements.21 
Although overall surgery rates declined 
with SSOP use, the absence of 
controlled studies made it difficult to 
determine whether nonconfirmation 
accurately identified surgeries that 
should not be performed.21 
Precertification requirements, designed 
to identify potentially unnecessary 
operations before they are performed, 
have also been used to contain 
costs associated with inappropriate 
surgeries. These requirements have 
been used both by public programs 
and commercial insurance carriers. For 
example, the Peer Review Organization 
(PRO) Program developed by Medicare 
in the 1980s required surgeons to 
obtain approval before patients could 
have certain surgeries. Screening criteria 
developed by individual PROs varied 
widely.21 Consideration could not be 
given to severity of disease, comorbidity, 
possible alternative treatments, or 
outcome probabilities; thus, the denial 
rate for PROs nationwide was only 
1.6% in 1990.24
More recently, pay-for-performance 
programs, which use financial incentives 
to encourage improvements in quality 
and efficiency, are increasingly used to 
contain health care costs and discourage 
overuse. In the Centers for Medicare 
and Medicaid Services Premier Hospital 
Quality Incentive Demonstration 
Project, small financial incentives 
(limited to 1% to 2% bonuses for selected 
Medicare populations) supported 
improvements in quality of care for 
CABG patients, including an average 
improvement in the CABG quality 
composite score from 84.8% to 97.4% 
during the first 3 years of the project.25, 26
With respect to eliminating overuse 
of cardiac revascularization, the NPP 
Priorities and Goals are commendable 
in light of the large number of these 
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procedures that are performed in 
the United States and their high 
cost. A more significant opportunity 
exists to reduce inappropriate use 
of PCI because it is more likely 
to be performed despite uncertain 
appropriateness. 
In order to eliminate the overuse 
of cardiac revascularization while 
ensuring the delivery of appropriate 
care, a variety of strategies will likely be 
needed. Although the literature lacks 
examples of specific interventions to 
improve rates of appropriate PCI and 
CABG use, real-time clinical decision-
support tools can improve adherence 
to evidence-based care and may be 
useful to reduce overuse of cardiac 
revascularization procedures. Even with 
these tools, however, large reductions in 
the overuse of PCI are unlikely to occur 
without associated financial “carrots and 
sticks” that are yet to be defined. Future 
research should focus on identifying 
and measuring the impact of specific 
tactics to improve appropriate use of 
cardiac revascularization procedures 
 
David J. Ballard, MD, MSPH, PhD, 
is Senior Vice President and Chief 
Quality Officer for the Baylor Health 
Care System, Dallas-Fort Worth, Texas.  
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Key Healthcare Quality Organization Websites
Agency for Healthcare Research and Quality (AHRQ) 
Federal agency charged with improving quality, safety, efficiency,  
and effectiveness of health care. 
www.ahrq.gov/qual/
AQA Alliance  
Focuses on improving patient safety, healthcare quality, and value by 
means of measuring performance at the physician/clinical group level and 
reporting outcomes with meaningful information for decision makers. 
www.aqaalliance.org/
Institute for Healthcare Improvement (IHI) 
Global resources for improving the quality of health care 
www.ihi.org/IHI/about
 
National Quality Forum 
Promotes change through development and implementation of national 
strategies for health care quality measurement and reporting 
www.qualityforum.org/
Healthcare Quality Organization Meetings of Interest:
American Society for Quality World Conference on Quality and Improvement 
St. Louis, Missouri – May 24-26, 2010 
http://wcqi.asq.org/
Annual Quality Colloquium at Harvard
A hybrid conference, Internet event, and training tool 
August 16-19, 2010 
http://www.qualitycolloquium.com/
Joint Commission Annual Conference on Quality and Safety 
Chicago, Illinois – June 23-25, 2010 
http://www.jcinc.com/callforpresentations2010/annualconference/
This newsletter was jointly developed and subject to editorial review by Jefferson School of Population Health and Lilly USA, LLC, and is supported through funding by Lilly USA, LLC. 
MG62587
